“Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?” (2026) Canadian Diabetes & Endocrinology Today, 4(1), pp. 5–9. doi:10.58931/cdet.2026.4149.